What Researchers Did
This review article summarized current treatment strategies for Amanita mushroom poisoning.
What They Found
Amanita mushroom poisoning frequently causes liver damage and accounts for a significant number of annual deaths, with reported fatality rates ranging from 11.3% to 51.3% of patients. Prognosis is mainly determined by the amount of mushroom ingested, with supportive therapy effective for sublethal exposures. Definitive treatments considered include hyperbaric oxygen, penicillin, silymarin, charcoal hemoperfusion, forced diuresis, and thioctic acid, though not all are clearly linked to increased survival.
What This Means for Canadian Patients
Canadian patients experiencing Amanita mushroom poisoning should seek immediate medical attention due to the high risk of liver damage and death. Treatment options may include supportive care, penicillin, or silymarin, with careful monitoring of blood glucose.
Canadian Relevance
This review article does not have a direct Canadian connection.
Study Limitations
A limitation is that some discussed treatment modalities were not clearly associated with increased survival, and the review's age may affect its current applicability.